Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>
<strong><a href="https://www.smartkarma.com/entities/genes-tech-group-holdings-company-limited" target="_blank" data-smartkarma-citation="entities:46022:1" rel="noopener">Genes Tech Group Holdings (8257 HK)</a></strong>, a turnkey solutions provider, has announced a rare, arm's-length Offer, by way of a Scheme. </li>
<li>The Offeror, privately-held Tinicum, is offering HK$0.245/share (not declared final), a 87% premium to last close, and a four-plus-year high.</li>
<li>Irrevocables comprising 69.79% of the register are supportive. Super clean deal</li>
</ul>



Genes Tech Group Holdings (8257 HK), a turnkey solutions provider, has announced a rare, arm's-length Offer, by way of a Scheme. 
The Offeror, privately-held Tinicum, is offering HK$0.245/share (not declared final), a 87% premium to last close, and a four-plus-year high.
Irrevocables comprising 69.79% of the register are supportive. Super clean deal


Genes Tech's (8257) Rare Arm's-Length Offer